Tianjin Ringpu Bio-Technology Co Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Ringpu Bio-Technology Co Ltd with three other
companies in this sector in China:
Zhongyuan Union Cell & Gene Engineering Corp Ltd
sales of 835.64 million Chinese Renmimbi [US$123.49 million]
of which 61%
was Scientific research service),
Beijing SL Pharmaceutical Co Ltd
(1.01 billion Chinese Renmimbi [US$149.24 million]
of which 98%
was Pharmaceuticals Industry), and
Jiangxi Boya Bio-Pharmaceutical Co Ltd
(946.57 million Chinese Renmimbi [US$139.88 million]
of which 56%
was Blood Plasma).
During the year ended December of 2016, sales at
Tianjin Ringpu Bio-Technology Co Ltd were 969.68 million Chinese Renmimbi (US$143.30 million).
increase of 22.4%
versus 2015, when the company's sales were 792.32 million Chinese Renmimbi.
Sales of Other Operation saw an increase
41.3% in 2016, from
15.97 million Chinese Renmimbi to 22.57 million Chinese Renmimbi.